Authors:
Moreno, R
Jiang, LY
Moehle, K
Zurbriggen, R
Gluck, R
Robinson, JA
Pluschke, G
Citation: R. Moreno et al., Exploiting conformationally constrained peptidomimetics and an efficient human-compatible delivery system in synthetic vaccine design, CHEMBIOCHEM, 2(11), 2001, pp. 838-843
Authors:
Correale, P
Cusi, MG
Sabatino, M
Micheli, L
Pozzessere, D
Nencini, C
Valensin, PE
Petrioli, R
Giorgi, G
Zurbriggen, R
Gluck, R
Francini, G
Citation: P. Correale et al., Tumour-associated antigen (TAA)-specific cytotoxic T cell (CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes, EUR J CANC, 37(16), 2001, pp. 2097-2103
Authors:
Cusi, MG
Correale, P
Valassina, M
Sabatino, M
Valensin, PE
Donati, M
Gluck, R
Citation: Mg. Cusi et al., Comparative study of the immune response in mice immunized with four live attenuated strains of mumps virus by intranasal or intramuscular route, ARCH VIROL, 146(7), 2001, pp. 1241-1248
Authors:
Pfeiffer, B
Moreno, R
Moehle, K
Zurbriggen, R
Gluck, R
Pluschke, G
Robinson, JA
Citation: B. Pfeiffer et al., Applications of protein epitope mimetics in vaccine design. A new supersecondary structure in the circumsporozoite protein of Plasmodium falciparum?, CHIMIA, 55(4), 2001, pp. 334-339
Authors:
Johansen, P
Estevez, F
Zurbriggen, R
Merkle, HP
Gluck, R
Corradin, G
Gander, B
Citation: P. Johansen et al., Towards clinical testing of a single-administration tetanus vaccine based on PLA/PLGA microspheres, VACCINE, 19(9-10), 2000, pp. 1047-1054
Authors:
Cusi, MG
Lomagistro, MM
Valassina, M
Valensin, PE
Gluck, R
Citation: Mg. Cusi et al., Immunopotentiating of mucosal and systemic antibody responses in mice by intranasal immunization with HLT-combined influenza virosomal vaccine, VACCINE, 18(25), 2000, pp. 2838-2842
Authors:
Kwissa, M
von Kampen, J
Zurbriggen, R
Gluck, R
Reimann, J
Schirmbeck, R
Citation: M. Kwissa et al., Efficient vaccination by intradermal or intramuscular inoculation of plasmid DNA expressing hepatitis B surface antigen under desmin promoter/enhancer control, VACCINE, 18(22), 2000, pp. 2337-2344
Authors:
Zurbriggen, R
Novak-Hofer, I
Seelig, A
Gluck, R
Citation: R. Zurbriggen et al., IRIV-adjuvanted hepatitis A vaccine: in vivo absorption and biophysical characterization, PROG LIPID, 39(1), 2000, pp. 3-18
Authors:
Schaad, UB
Buhlmann, U
Burger, R
Ruedeberg, A
Wilder-Smith, A
Rutishauser, M
Sennhauser, F
Herzog, C
Zellmeyer, M
Gluck, R
Citation: Ub. Schaad et al., Comparison of immunogenicity and safety of a virosome influenza vaccine with those of a subunit influenza vaccine in pediatric patients with cystic fibrosis, ANTIM AG CH, 44(5), 2000, pp. 1163-1167
Authors:
Cusi, MG
Zurbriggen, R
Valassina, M
Bianchi, S
Durrer, P
Valensin, PE
Donati, M
Gluck, R
Citation: Mg. Cusi et al., Intranasal immunization with mumps virus DNA vaccine delivered by influenza virosomes elicits mucosal and systemic immunity, VIROLOGY, 277(1), 2000, pp. 111-118
Authors:
Gluck, R
Mischler, R
Durrer, P
Furer, E
Lang, AB
Herzog, C
Cryz, SJ
Citation: R. Gluck et al., Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant, J INFEC DIS, 181(3), 2000, pp. 1129-1132
Authors:
Rohrschneider, K
Bultmann, S
Gluck, R
Kruse, FE
Fendrich, T
Volcker, HE
Citation: K. Rohrschneider et al., Scanning laser ophthalmoscope fundus perimetry before and after laser photocoagulation for clinically significant diabetic macular edema, AM J OPHTH, 129(1), 2000, pp. 27-32
Authors:
Gulich, MS
Matschiner, A
Gluck, R
Zeitler, HP
Citation: Ms. Gulich et al., Improving diagnostic accuracy of bacterial pharyngitis by near patient measurement of C-reactive protein (CRP), BR J GEN PR, 49(439), 1999, pp. 119-121
Authors:
De Schreye, D
Gluck, R
Jorgensen, J
Leuschel, M
Martens, B
Sorensen, MH
Citation: D. De Schreye et al., Conjunctive partial deduction: foundations, control, algorithms, and experiments, J LOGIC PR, 41(2-3), 1999, pp. 231-277
Citation: R. Zurbriggen et R. Gluck, Immunogenicity of IRIV- versus alum-adjuvanted diphtheria and tetanus toxoid vaccines in influenza primed mice, VACCINE, 17(11-12), 1999, pp. 1301-1305
Authors:
Khalil, M
Poltera, AA
Al-Howasi, M
Herzog, C
Gerike, E
Wegmuller, B
Gluck, R
Citation: M. Khalil et al., Response to measles revaccination among toddlers in Saudi Arabia by the use of two different trivalent measles-mumps-rubella vaccines, T RS TROP M, 93(2), 1999, pp. 214-219
Citation: U. Gluck et al., Phase 1 evaluation of intranasal virosomal influenza vaccine with and without Escherichia coli heat-labile toxin in adult volunteers, J VIROLOGY, 73(9), 1999, pp. 7780-7786
Authors:
Poltl-Frank, F
Zurbriggen, R
Helg, A
Stuart, F
Robinson, J
Gluck, R
Pluschke, G
Citation: F. Poltl-frank et al., Use of reconstituted influenza virus virosomes as an immunopotentiating delivery system for a peptide-based vaccine, CLIN EXP IM, 117(3), 1999, pp. 496-503